Sonnet BioTherapeutics I... (SONN)
1.54
0.00 (0.00%)
At close: Feb 28, 2025, 3:59 PM
1.50
-2.60%
After-hours: Feb 28, 2025, 04:56 PM EST
Sonnet BioTherapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
38
Upside
2367.53
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Keay Nakae (0.39)
| Chardan Capital | Buy | Maintains | 30 20 | Dec 20, 2024 |
Keay Nakae (0.39)
| Chardan Capital | Buy | Maintains | 240 240 | Aug 23, 2024 |
Keay Nakae (0.39)
| Chardan Capital | Buy | Maintains | 240 240 | May 28, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.